ADSR03 Adapta SR
Implantable Pulse Generator (IPG)
ADSR03 Adapta SR

Device Survival Probability


    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr at 87.0 mo    
% Excluding Normal Battery Depletion 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0    
% Including Normal Battery Depletion 100.0 99.9 99.8 99.4 98.6 97.0 93.2 93.2    
#   61920 47098 34597 24019 14955 7279 1207 161    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.

Advisories For This Model

  • There are no advisories for this model.

Performance Notes For This Model

    • There are no performance notes for this model.

Product Characteristics

Generator Type IPG
Max. Delivered Energy N/A
Connector Style 3.2mm Long Pin
Serial Number Prefix NWP, PWP
Mass 22.5 g
Volume 10.5 cc
Waveform N/A
Hide this content
3.2mm Long Pin

Estimated Longevity

Amplitude Setting 500 Lead Ω 1000 Lead Ω
Low 2.5 V (A, RV) 7.4 | 8.9* 7.9 | 9.7*
Nominal 3.5 V (A, RV) 6.5 | 7.7* 7.5 | 9.1*
High 5.0 V (A, RV) 5.1 | 5.9* 6.3 | 7.4*

*The second longevity numbers provided apply to the N-series Adapta ADSR03 product. The N-series products have increased longevity because of improved electronic circuitry. Click on "Other Articles" for more information on the N-series longevity. Longevity estimates based on the following device usage. Pace/Sense Mode VVI ; Right Ventricle Pulse Width 0.4 ms; Lower Pace Rate 60 bpm; Right Ventricle Percent Paced 100 %; EGM Prestorage ON ; Upper Sensing Rate 130 ppm; EGM Prestorage ON Time 1 ; Hide this content


EOS Indication

From the point that the ERI is set, the pacemaker will operate at ERI conditions for approximately three months for typical pacemaker configurations during the normal operating life.


Distribution Data

US Market Release2006-07-17
CE Approval Date2005-09-20
Registered USA Implants1693
Estimated Active USA Implants1131
Normal Battery Depletions8
US Market Release2006-07-17
CE Approval Date2005-09-20
Estimated WW Distribution21069
Normal Battery Depletions138

Malfunctions (USA)

Therapy Function Not Compromised
Therapy Function Compromised

Malfunctions (WW)

Therapy Function Not Compromised 2
Electrical Component 1
Other 1
Therapy Function Compromised 0

Recommended Replacement (RRT)

Telemetry indication. Rate and mode change to 65 ppm and VVI respectively (VOO/65 with magnet).

Data as of January 31, 2014 301050